Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis

Journal of the American Academy of Dermatology

Volumn 56, Issue 2 SUPPL., 2007, Pages

  Safa, Gilles ^a   Loppin, Marion ^a   Bousser, Anne Marie ^a   Barbarot, Sebastien ^b  

^a Centre Hospitalier de Saint Brieuc   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETANERCEPT; ETRETIN; METHOTREXATE;

ABSENCE OF SIDE EFFECTS; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ERYTHEMA; HUMAN; HUMAN TISSUE; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; SCHOOL CHILD; SKIN BIOPSY; SKIN TOXICITY; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

CHILD; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MALE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846039752     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.01.064     Document Type: Article

References (5)

1. Leman J., and Burden D. Psoriasis in children: a guide to its diagnosis and management. Paediatr Drugs 3 (2001) 673-680
2. Farber E.M., and Nall L. Childhood psoriasis. Cutis 64 (1999) 309-314
3. Mease P., and Goffe B.S. Diagnosis and treatment of psoriatic arthritis. J Am Acad Dermatol 52 (2005) 1-19
4. Nash P.T., and Florin T.H. Tumor necrosis factor inhibitors. Med J Aust 183 (2005) 205-208
5. Leonardi C.L., Powers J.L., Matherson R.T., Goffe B.S., Zitnik R., Wang A., et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349 (2003) 2014-2022